In this episode of Talks at GS, Dr. Michael Mina of the Harvard T.H. Chan School of Public Health discusses the evolving understanding of COVID-19 biology and epidemiology and approaches to “flatten the curve” in the context of diagnostics, potential therapeutics and vaccines.
Our weekly newsletter with insights and intelligence from across the firm
By submitting this information, you agree to receive marketing emails from Goldman Sachs and accept our privacy policy. You can opt-out at any time.